Global Health Governance and Tropical Diseases

Abstract

Standard-Nutzungsbedingungen:Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Zwecken und zum Privatgebrauch gespeichert und kopiert werden.Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich machen, vertreiben oder anderweitig nutzen.Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, gelten abweichend von diesen Nutzungsbedingungen die in der dort genannten Lizenz gewährten Nutzungsrechte. www.econstor.eu Terms of use: Documents in P O L I C Y P A P E R S E R I E S ABSTRACT Global Health Governance and Tropical DiseasesGlobal Health Governance (GHG) comprises the means adopted to promote decision making on actions to protect and promote global health, along with the underlying architecture of global health institutions, initiatives, and actors that facilitate these means. GHG is a key factor influencing health outcomes throughout the world. Over the past decade, the GHG system has increased dramatically in size and complexity. In the past half century, GHG has achieved successes against some tropical diseases, but going forward, it faces new challenges. The current GHG system has several weaknesses -lack of participation, transparency, accountability, and efficiency -but the system also has several strengthscapacity for innovation, flexibility, and the ability to attract a motivated workforce and to encourage entrepreneurship. To adequately address tropical diseases in the future, GHG reforms will need to address some of the weaknesses while preserving the strengths.JEL Classification: F35, F68, I18

Nurses' roles and challenges to providing care for tropical diseases: A scoping review

“…Tropical diseases can spread globally due to increased travel accessibility, climate change, and environmental factors affecting disease vectors (Alonso et al, 2017;Hotez & Gurwith, 2011). Tropical diseases' high prevalence of morbidity and mortality causes a significant economic burden on developing countries, most notably through malaria, dengue fever, and Human African Trypanosomiasis (sleeping sickness) (Bärnighausen et al, 2013). While tropical diseases have a low mortality prevalence in affluent countries, their high morbidity can negatively impact life and productivity (Hunter, 2014).…”